Egyptian teleradiology startup Rology receives funding from global healthcare leaders

Egyptian startup Rology, an AI-assisted teleradiology platform, has announced the successful closing of its growth funding round, which includes participation from healthcare industry leaders including the Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve Innovation Future.

Founded by Amr Abodraiaa, Moaaz Hossam, Mahmoud Eldefrawy and Bassam Khallaf in October 2017, Rology has built a cloud-based platform that provides intelligent matchmaking between patients and remote radiologists, tackling the global shortage of the latter.

The startup’s technology can be launched with zero setup costs for hospitals as well as for radiologists, and gives radiologists the freedom to work from anywhere in the world as long as they have access to a laptop and internet connection. 

Rology closed a pre-Series A round of funding in April 2022, and then expanded into Saudi Arabia, which has the largest healthcare sector in the region, with the acquisition of Arkan United, in 2023. It has also launched in Kenya, and is now set for further growth after securing funding from investors including the Philips Foundation, Johnson & Johnson Impact Ventures, Sanofi Global Health Unit’s Impact Fund, and MIT Solve Innovation Future.

“This round brings together mission-aligned leaders across industry, research, and impact investing to advance AI reporting and expand access to high-quality radiology across MEA,” said Abodraiaa.

With over 1.2 million lives saved and more than 1.3 million radiology reports delivered to more than 300 hospitals across 13 countries, with a network of over 200 radiologists, Rology has become a critical infrastructure layer in healthcare systems across Africa and the Middle East, covering both private and public health institutions, including those in fragile and underserved regions.

As radiologist shortages and increasing imaging demand create bottlenecks globally, Rology addresses the urgent need for faster, higher-quality diagnostics through its end-to-end teleradiology platform and AI models. Its FDA 510(k) cleared teleradiology system delivers superior clinical accuracy (99.89%) and up to 25 per cent cost savings on diagnostic reporting.

“As a follow-on lead investor, Philips Foundation reaffirms its confidence in Rology’s innovative model that bridges the diagnostic gap and strengthens access to quality care. This investment reflects our belief in human-centered technology that gives clinicians time back and makes advanced diagnostics available where they are needed most,” said Eddine Sarroukh, head of Philips Foundation. 

“Supporting companies like Rology is central to our mission of advancing equitable access to healthcare by combining digital innovation with practical, system-level impact.”